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Hypothesis
The addition of SOCS3 to IL-10 polarized M2c anti-inflammatory macrophages enhances the expression of MERTK receptor when compared to SOCS3 alone, whereas on the other hand SOCS1 does not affect the expression of MERTK receptor
Abstract
Macrophages are phagocytic cells located in tissues, organs
and even circulated within our body as white blood cells.
Receptor tyrosine kinase Mer (MERTK) helps in clearing dead
neutrophils and other apoptotic cells from damaged tissue
sites preventing chronic inflammation and autoimmune
disorders. MERTK receptor is expressed mostly on anti-
inflammatory M2c macrophages.
The current study explores the expression rate of the
phagocytic receptor MERTK, on macrophages polarized with
either IL-10 (M2 cells) or IL-4 or IL-13 (M2a macrophages),
following treatment with the suppressor of cytokine signaling
SOCS3 in comparison with macrophage polarization with only
IL-10 or IL-4 or IL-13. The study exhibits an enhancement in the
expression of the phagocytic MERTK receptor on the surface of
IL-10 polarized M2c macrophage when treated with SOCS3 in
comparison to IL-10 polarized M2c macrophage, IL-4 polarized
M2a macrophage and IL- 13 treated M2a macrophage.
Background
 Macrophages are critical in detecting tissue damage and
infection. Resident tissue macrophages initiate the signals
for inflammation recruiting neutrophils and blood
monocytes which mature into macrophages at sites of
infection and aids in the resolution of inflammation
 Based on the local cytokine milieu in tissue sites,
macrophages may be polarized into pro-inflammatory M1
or anti-inflammatory M2 phenotypes
 Phosphatidylserine (PtdSer) present on the surface of
apoptotic cells release “eat me” signals which are
recognized by the two “bridging ligands” of MERTK
receptor, Gas6 and ProS. The binding of the ligands to
PtdSer initiates intracellular signals leading to phagocytosis
of the cell
 MERTK aids in the maintenance of tissue homeostasis and
wound healing
 SOCS are a family of intracellular cytokine activated proteins
 Capan (2017) showed an increase in phagocytosis of N2a
tumor cells by SOCS3-treated IL-10 polarized M2c
macrophages by blocking the calreticulin (CRT) “eat-me”
signal
 Madhkhali (2019) noted an upregulation in the phagocytic
capacity of these SOCS3 treated macrophages for N2a
tumor cells
CTCF =  Integrated Density – (Area of  selected cell x  
Mean fluorescence of background readings)
Results
Conclusion
MERTK receptor expression is enhanced by addition of SOCS3 to M2c macrophages when compared with SOCS3+IL-13 M2a macrophages
SOCS1 acts as a negative regulator of MERTK when treated with M0 macrophage and with IL-10 polarized M2c phenotype
The increase in the expression of MERTK receptor on IL-13 polarized M2a macrophages, but not when compared to IL-4 polarized M2a
macrophage, showcase the dynamic, diverse, and plastic nature of macrophages as they readily switch from one phenotype to another
The current study supports the data of Capan (2017) and Madhkhali (2019) on the positive impact of SOCS3
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